The Female Health Company Schedules First Quarter Conference Call for February 10, 2009
February 03 2009 - 7:30AM
PR Newswire (US)
CHICAGO, Feb. 3 /PRNewswire-FirstCall/ -- The Female Health Company
(NYSE Alternext: FHC) today announced that it will host an investor
conference call to discuss its operating results for the first
quarter of FY2009 at 11:00 a.m. Eastern Time (EST) on Tuesday,
February 10, 2009. The Company plans to report its first quarter
operating results earlier the same day. Shareholders and other
interested parties may participate in the conference call by
dialing 800-860-2442 (international participants dial 412-858-4600)
and asking to be connected to "The Female Health Company Conference
Call", a few minutes before 11:00 a.m. EST on February 10, 2009. A
replay of the call will be available one hour after the call
through 5:00 p.m. EST on February 24, 2009 by dialing 877-344-7529
(international callers dial 412-317-0088) and entering the
conference ID 427502. About The Female Health Company The Female
Health Company (FHC), headquartered in Chicago, IL, is the maker of
the FC Female Condom (FC1 and FC2), a revolutionary option offering
women dual protection against both sexually transmitted diseases,
including HIV/AIDS, and unintended pregnancy. FHC was created as a
worldwide company in February 1996 with the purchase of Chartex
Resources Ltd., the holder of exclusive worldwide rights to FC1.
The Company holds exclusive product and technology patents for FC1
in the United States, Australia, Brazil, Canada, France, Germany,
Italy, Spain, the United Kingdom, the People's Republic of China,
South Korea and Japan. Patents are pending for FC2. FHC is the sole
manufacturer and marketer of the FC1 and FC2 female condoms in the
world. The Female Health Company and its partners currently market
the Female Condom under FC Female Condom(R), FC2 Female Condom(R),
Reality(R), Femidom(R), Femy(R), and Care(R) in the rest of the
world. "Safe Harbor" statement under the Private Securities
Litigation Reform Action of 1995: The statements in this release
which are not historical fact are forward-looking statements based
upon the Company's current plans and strategies, and reflect the
Company's current assessment of the risks and uncertainties related
to its business, including such things as product demand and market
acceptance; the economic and business environment and the impact of
government pressures; currency risks; capacity; efficiency and
supply constraints; and other risks detailed in the Company's press
releases, shareholder communications and Securities and Exchange
Commission filings. Actual events affecting the Company and the
impact of such events on the Company's operations may vary from
those currently anticipated. For more information about the Female
Health Company visit the Company's web site at
http://www.femalehealth.com/ and http://www.femalecondom.org/. If
you would like to be added to an e-mail alert list, please send an
e-mail to Contacts: William R. Gargiulo, Jr. 231-526-1244 Donna
Felch, CFO 312-595-9123 DATASOURCE: The Female Health Company
CONTACT: William R. Gargiulo, Jr., +1-231-526-1244, or Donna Felch,
CFO, +1-312-595-9123, both for The Female Health Company Web Site:
http://www.femalehealth.com/
Copyright